» Articles » PMID: 35284624

Exosomal MiR-205-5p Enhances Angiogenesis and Nasopharyngeal Carcinoma Metastasis by Targeting

Abstract

The aim of this study was to investigate whether and how exosomal miR-205-5p regulated angiogenesis and nasopharyngeal carcinoma (NPC) metastasis. We found that up-regulated serum exosomal miR-205-5p levels were associated with NPC progression and worse overall survival of NPC patients. miR-205-5p over-expression significantly increased tube formation, wound healing, migration and invasion of NPC cells, and lung metastasis of NPC tumors, whereas miR-205-5p inhibition had opposite effects. Exosomal miR-205-5p from NPC cells promoted the migration, tube formation, and microvessel density (MVD) of HUVECs and . Furthermore, bioinformatics-, luciferase reporter-, and biotinylated miR-205-5p-based pull-down assays indicated that miR-205-5p directly bound to the 3' UTR of (). Exosomal miR-205-5p targeted to enhance the EGFR/ERK signaling and MMP2/MMP9 expression, promoting angiogenesis and NPC metastasis, which was abrogated by DSC2 over-expression. Finally, the levels of miR-205-5p transcripts were positively correlated with MVD but negatively with DSC2 expression in NPC tissues, and patients with miR-205/DSC2 NPC had worse overall survival. In conclusion, exosomal miR-205-5p promotes angiogenesis and NPC metastasis by targeting DSC2 to enhance EGFR/ERK signaling and MMP expression. This exosomal/miR-205-5p/EGFR/ERK axis may be a new therapeutic target for intervention of NPC metastasis.

Citing Articles

Long non‑coding RNA ABHD11‑AS1 inhibits colorectal cancer progression through interacting with EGFR to suppress the EGFR/ERK signaling pathway.

Tan S, Li S, Xia L, Jiang X, Ren Z, Peng Q Int J Oncol. 2025; 66(3).

PMID: 39950321 PMC: 11844336. DOI: 10.3892/ijo.2025.5726.


Emerging roles of extracellular vesicles in oral and maxillofacial areas.

Wang Q, Sun J, Jiang H, Yu M Int J Oral Sci. 2025; 17(1):11.

PMID: 39900916 PMC: 11791077. DOI: 10.1038/s41368-024-00341-9.


Circulating miR-23b-3p, miR-30e-3p, and miR-205-5p as Novel Predictive Biomarkers for Ramucirumab-Paclitaxel Therapy Outcomes in Advanced Gastric Cancer.

Piccinno E, Schirizzi A, Scalavino V, De Leonardis G, Donghia R, Fantasia A Int J Mol Sci. 2025; 25(24.

PMID: 39769259 PMC: 11677161. DOI: 10.3390/ijms252413498.


Utilization of miRNAs as Biomarkers for the Diagnosis, Prognosis, and Metastasis in Gynecological Malignancies.

Lazaridis A, Katifelis H, Kalampokas E, Lambropoulou D, Aravantinos G, Gazouli M Int J Mol Sci. 2024; 25(21).

PMID: 39519256 PMC: 11546551. DOI: 10.3390/ijms252111703.


Exosomal miRNAs: the tumor's trojan horse in selective metastasis.

Bayat M, Nahand J Mol Cancer. 2024; 23(1):167.

PMID: 39164756 PMC: 11334467. DOI: 10.1186/s12943-024-02081-0.


References
1.
Yan S, Wang H, Chen X, Liang C, Shang W, Wang L . MiR-182-5p inhibits colon cancer tumorigenesis, angiogenesis, and lymphangiogenesis by directly downregulating VEGF-C. Cancer Lett. 2020; 488:18-26. DOI: 10.1016/j.canlet.2020.04.021. View

2.
Zhang D, Vu L, Ismail N, Le M, Grimson A . Landscape of extracellular vesicles in the tumour microenvironment: Interactions with stromal cells and with non-cell components, and impacts on metabolic reprogramming, horizontal transfer of neoplastic traits, and the emergence of therapeutic.... Semin Cancer Biol. 2021; 74:24-44. DOI: 10.1016/j.semcancer.2021.01.007. View

3.
Chu P, Liang A, Jiang A, Zong L . miR-205 regulates the proliferation and invasion of ovarian cancer cells via suppressing PTEN/SMAD4 expression. Oncol Lett. 2018; 15(5):7571-7578. PMC: 5920363. DOI: 10.3892/ol.2018.8313. View

4.
Dong Y, Si J, Li W, Liang L, Zhao J, Zhou M . miR-200a/miR-141 and miR-205 upregulation might be associated with hormone receptor status and prognosis in endometrial carcinomas. Int J Clin Exp Pathol. 2015; 8(3):2864-75. PMC: 4440104. View

5.
Lu J, Liu Q, Wang F, Tan J, Deng Y, Peng X . Exosomal miR-9 inhibits angiogenesis by targeting MDK and regulating PDK/AKT pathway in nasopharyngeal carcinoma. J Exp Clin Cancer Res. 2018; 37(1):147. PMC: 6044044. DOI: 10.1186/s13046-018-0814-3. View